Press M - Search Results

1

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, Shak S, Stewart SJ, Press M. Vogel CL, et al. Among authors: press m. J Clin Oncol. 2002 Feb 1;20(3):719-26. doi: 10.1200/JCO.2002.20.3.719. J Clin Oncol. 2002. PMID: 11821453 Clinical Trial.

2

HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.

Bacus SS, Bacus JW, Slamon DJ, Press MF. Bacus SS, et al. Among authors: press mf. Arch Pathol Lab Med. 1990 Feb;114(2):164-9. Arch Pathol Lab Med. 1990. PMID: 1967930

3

Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues.

Press MF, Cordon-Cardo C, Slamon DJ. Press MF, et al. Oncogene. 1990 Jul;5(7):953-62. Oncogene. 1990. PMID: 1973830

4

HER-2/neu oncogene amplification and expression in breast and ovarian cancers.

Press MF, Jones LA, Godolphin W, Edwards CL, Slamon DJ. Press MF, et al. Prog Clin Biol Res. 1990;354A:209-21. Prog Clin Biol Res. 1990. PMID: 1978943 Review. No abstract available.

5

Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.

Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG, et al. Press MF, et al. Cancer Res. 1994 Nov 1;54(21):5675-82. Cancer Res. 1994. PMID: 7522962

6

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

Press MF, Hung G, Godolphin W, Slamon DJ. Press MF, et al. Cancer Res. 1994 May 15;54(10):2771-7. Cancer Res. 1994. PMID: 7909495

7

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

Pauletti G, Godolphin W, Press MF, Slamon DJ. Pauletti G, et al. Among authors: press mf. Oncogene. 1996 Jul 4;13(1):63-72. Oncogene. 1996. PMID: 8700555

8

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ. Press MF, et al. J Clin Oncol. 1997 Aug;15(8):2894-904. doi: 10.1200/JCO.1997.15.8.2894. J Clin Oncol. 1997. PMID: 9256133

9

Clonal analysis of bilateral breast cancer.

Shibata A, Tsai YC, Press MF, Henderson BE, Jones PA, Ross RK. Shibata A, et al. Among authors: press mf. Clin Cancer Res. 1996 Apr;2(4):743-8. Clin Cancer Res. 1996. PMID: 9816225

10

Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens.

Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L. Press MF, et al. J Clin Oncol. 2002 Jul 15;20(14):3095-105. doi: 10.1200/JCO.2002.09.094. J Clin Oncol. 2002. PMID: 12118023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Search Page

Filters